These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2477648)

  • 41. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
    Alexander S; Hubbard SC; Strominger JL
    J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Homotypic aggregation of pre-B leukemic cell lines by antibodies to VLA integrins correlates with their expression of CD9.
    Letarte M; Seehafer JG; Greaves A; Masellis-Smith A; Shaw AR
    Leukemia; 1993 Jan; 7(1):93-103. PubMed ID: 7678118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study.
    Abshire TC; Buchanan GR; Jackson JF; Shuster JJ; Brock B; Head D; Behm F; Crist WM; Link M; Borowitz M
    Leukemia; 1992 May; 6(5):357-62. PubMed ID: 1534389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of candidate target antigens for antibody-based immunotherapy in childhood B-cell precursor ALL.
    Gudowius S; Recker K; Laws HJ; Dirksen U; Tröger A; Wieczorek U; Furlan S; Göbel U; Hanenberg H
    Klin Padiatr; 2006; 218(6):327-33. PubMed ID: 17080335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Demonstration of two distinct light chains in HLA-DR-associated antigens by two-dimensional gel electrophoresis.
    de Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
    Eur J Immunol; 1982 Mar; 12(3):214-21. PubMed ID: 6178597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serological biochemical and functional characterisation of three different HLA-DR monoclonal antibodies derived from C57BL6 mice.
    Sachs JA; Fernandez N; Kurpisz M; Okoye R; Ogilvie J; Awad J; Labeta M; Festenstein H
    Tissue Antigens; 1986 Oct; 28(4):199-207. PubMed ID: 2949394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. B-lineage phenotype of lymphoblastoid cell lines from patients with X-linked agammaglobulinemia.
    Tsuchiya S; Fujie H; Konno T
    Tohoku J Exp Med; 1991 Apr; 163(4):289-94. PubMed ID: 1652799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
    Hurwitz CA; Gore SD; Stone KD; Civin CI
    Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical comparison of HLA-DR molecules derived from autologous human T and B lymphoblasts.
    Altevogt P; Fohlman J; Kurnick JT; Peterson P; Wigzell H
    Eur J Immunol; 1980 Dec; 10(12):908-14. PubMed ID: 6258924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
    Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
    J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a bone marrow culture for maintenance and growth of normal human B cell precursors.
    Wolf ML; Buckley JA; Goldfarb A; Law CL; LeBien TW
    J Immunol; 1991 Nov; 147(10):3324-30. PubMed ID: 1719075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional association of class II antigens with cell surface binding of Epstein-Barr virus.
    Reisert PS; Spiro RC; Townsend PL; Stanford SA; Sairenji T; Humphreys RE
    J Immunol; 1985 Jun; 134(6):3776-80. PubMed ID: 2985696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation of a normal B cell subset with a Burkitt-like phenotype and transformation in vitro with Epstein-Barr virus.
    Gregory CD; Edwards CF; Milner A; Wiels J; Lipinski M; Rowe M; Tursz T; Rickinson AB
    Int J Cancer; 1988 Aug; 42(2):213-20. PubMed ID: 2841246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Some Epstein-Barr virus-transformed B lymphoblastoid cell lines have an altered structure around the mixed lymphocyte culture-inducing domain on DR molecules.
    Nagayoshi T; Morito F; Kaneoka H; Yamaguchi M
    Fukuoka Igaku Zasshi; 1986 May; 77(5):287-92. PubMed ID: 3017826
    [No Abstract]   [Full Text] [Related]  

  • 58. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
    Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
    Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
    Santoli D; Francis MK; Matera L; Ferrero D
    J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. B-lymphocyte associated differentiation antigen expression by 'non-B, non-T' acute lymphoblastic leukemia.
    Flug F; Dodson L; Wolff J; Guarini L; Rausen A; Wang CY; Knowles DM
    Leuk Res; 1985; 9(8):1051-8. PubMed ID: 2931557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.